{
    "Rank": 517,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT00148993",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "100798-HMO-CTIL"
                },
                "Organization": {
                    "OrgFullName": "Hadassah Medical Organization",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors",
                "OfficialTitle": "Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors"
            },
            "StatusModule": {
                "StatusVerifiedDate": "July 2005",
                "OverallStatus": "Withdrawn",
                "WhyStopped": "PI (Prof. Slavin) not longer work at Hadassah",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "July 1998"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "July 2005",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "September 7, 2005",
                "StudyFirstSubmitQCDate": "September 7, 2005",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "September 8, 2005",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "April 7, 2011",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "April 8, 2011",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyOldNameTitle": "Shimon Slavin MD",
                    "ResponsiblePartyOldOrganization": "The International Center for Cell Therapy & Cancer Immunotherapy (CTCI)"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Hadassah Medical Organization",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "The International Center for Cell Therapy & Cancer Immunotherapy (CTCI)",
                            "CollaboratorClass": "UNKNOWN"
                        }
                    ]
                }
            },
            "OversightModule": {},
            "DescriptionModule": {
                "BriefSummary": "The goal of this study is to apply allogeneic tumor cell vaccination for immunotherapy in patients with micro-metastatic disease and/or in patients at high risk disease progression. The present study will use allogeneic tumor cell lines for tumor cell vaccines that share MHC determinants with the patient aiming to overcome possible restriction of antigen presentation."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Metastatic Solid Tumors"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Tumor cell vaccine"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Phase 1",
                        "Phase 2"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "Non-Randomized",
                    "DesignInterventionModel": "Single Group Assignment",
                    "DesignMaskingInfo": {
                        "DesignMasking": "None (Open Label)"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "100",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Biological",
                            "InterventionName": "Tumor Cell Vaccine"
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Investigate the feasibility of anti-tumor immune response by allogeneic tumor cell vaccine using tumor cells that share MHC determinants with the patient."
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Investigate the feasibility of immune responses against cancer cells by combining allogeneic TCV with indomethacin, cimetidine, tetanus and rIL-2."
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with measurable metastatic disease or disease resistant to chemotherapy or with minimal residual disease at high risk to relapse.\n\nExclusion Criteria:\n\nKarnofsky less than 60%. Unrelated condition requiring the use of any cytotoxic agents or immunosuppressive agents which may interfere with optimal immune response.",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "18 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "shimon slavin, MD",
                            "OverallOfficialAffiliation": "The International Center for Cell Therapy & Cancer Immunotherapy (CTCI)",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "The International Center for Cell Therapy & Cancer Immunotherapy (CTCI)",
                            "LocationCity": "Tel Aviv",
                            "LocationZip": "64239",
                            "LocationCountry": "Israel"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000009369",
                            "ConditionMeshTerm": "Neoplasms"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M17050",
                            "InterventionBrowseLeafName": "Vaccines",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}